Diabetes news this morning carries the story that a Harvard Medical School Professor, Denise Faustma, will investigate how tuberculosis therapy could have a role to play in curing type 1 diabetes .
A research team started a clinical trial late last year, the aim of which is to determine whether a vaccine that was once used for TB could influence type 1 diabetes .
Prof. Faustman was reported as commenting: “Most trials trying to reverse the disease are for new-onset diabetes. This is one of the first trials actually trying to manipulate the immune system in someone who has a long-standing disease.”
The vaccine prompts low-grade inflammation that could stop immune system cells from destroying pancreatic beta cells, that produce insulin . The vaccine has been used for around 80 years, and is thought to be completely safe.

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Conversation about doctors’ appointments occurring virtually rumbles on

More than half of GP appointments are still being delivered remotely in…

Coronavirus: UK instructed to stay at home this weekend

Health Secretary Matt Hancock has said that staying at home this weekend…

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…